Cdc13 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc13 monoclonal antibodies for research in cell cycle regulation and telomere maintenance. Validated applications include western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc13 plays a critical role in protecting and maintaining telomeres, significantly impacting cellular aging and genomic stability. By preventing chromosome end degradation, Cdc13 influences cell proliferation and has implications in cancer development. Research focusing on Cdc13 continues to reveal important mechanisms in cellular aging processes. Understanding Cdc13's functions provides new perspectives for developing targeted therapies in age-related diseases and cancer treatment. Investigating Cdc13's role in telomere maintenance opens new avenues for understanding cellular longevity. Current studies highlight Cdc13's significance in maintaining chromosomal integrity and preventing premature cellular aging. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular aging and cancer biology.